LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 38.22 | 771.67 | 2316 | 4299 | 0.5387 | 0.5581 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.44 | 771.67 | 2798 | 4738 | 0.5905 | 0.6355 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 40.44 | 771.67 | 2502 | 4738 | 0.5280 | 0.5671 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.67 | 771.67 | 3038 | 5155 | 0.5893 | 0.6489 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 42.67 | 771.67 | 2666 | 5155 | 0.5171 | 0.5722 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.89 | 771.67 | 3197 | 5541 | 0.5769 | 0.6483 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 44.89 | 771.67 | 2855 | 5541 | 0.5152 | 0.5840 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.11 | 771.67 | 3369 | 5941 | 0.5670 | 0.6495 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 47.11 | 771.67 | 3008 | 5941 | 0.5063 | 0.5872 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.33 | 771.67 | 3577 | 6392 | 0.5596 | 0.6534 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 49.33 | 771.67 | 3248 | 6392 | 0.5081 | 0.6019 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 51.55 | 771.67 | 3796 | 6829 | 0.5558 | 0.6594 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 51.55 | 771.67 | 3446 | 6829 | 0.5046 | 0.6091 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.77 | 771.67 | 4010 | 7256 | 0.5526 | 0.6648 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 53.77 | 771.67 | 3688 | 7256 | 0.5082 | 0.6223 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.99 | 771.67 | 4289 | 7690 | 0.5577 | 0.6772 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 55.99 | 771.67 | 4033 | 7690 | 0.5244 | 0.6464 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.21 | 771.67 | 4534 | 8085 | 0.5608 | 0.6862 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.21 | 771.67 | 4174 | 8085 | 0.5162 | 0.6455 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 60.44 | 771.67 | 4796 | 8530 | 0.5622 | 0.6939 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 60.44 | 771.67 | 4438 | 8530 | 0.5202 | 0.6564 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.66 | 771.67 | 4957 | 8978 | 0.5521 | 0.6911 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 62.66 | 771.67 | 4684 | 8978 | 0.5217 | 0.6642 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.88 | 771.67 | 5153 | 9447 | 0.5455 | 0.6912 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 64.88 | 771.67 | 4887 | 9447 | 0.5173 | 0.6666 | MN20160304_L01 | G15 |